Multiple imaging mode tissue marker

US9579077B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9579077-B2
Application numberUS-51869507-A
CountryUS
Kind codeB2
Filing dateDec 12, 2007
Priority dateDec 12, 2006
Publication dateFeb 28, 2017
Grant dateFeb 28, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An intracorporeal marker for marking a site within living tissue of a host having a body of porous hydroxyapatite whose physical properties permit the body to be distinguished from human soft tissue under visualization using ultrasonic and radiation imaging modalities.

First claim

Opening claim text (preview).

The invention claimed is: 1. An intracorporeal marker, for marking a site within living tissue of a host, comprising: a body comprised of first and second distinct materials, the body having a core region made of the first material completely surrounded by an outer region made of the second material, the first material being comprised of porous hydroxyapatite having physical properties that permit the body to be distinguished from human soft tissue under visualization using ultrasonic and radiation imaging modalities, the second material being comprised of a second hydroxyapatite, and wherein the porous hydroxyapatite of the core region has a first porosity and the second hydroxyapatite of the outer region has a second porosity, wherein the first porosity of the porous hydroxyapatite of the core region is higher than the second porosity of the second hydroxyapatite of the outer region. 2. The marker of claim 1 , wherein the body has a cylindrical shape. 3. The marker of claim 1 , wherein the body has gas-filled pores. 4. The marker of claim 1 , wherein the outer region has a surface that is water-impermeable. 5. An intracorporeal marker for marking a site within living tissue of a host, comprising: a porous body having a central region and a surface that surrounds the central region, the body having pores filled with gas, the sizes of the pores and the gas being such that the body is configured to be visualized under ultrasound, wherein the porous body comprises a first dense hydroxyapatite at the central region, a second dense hydroxyapatite at the surface, and a porous hydroxyapatite between the central region and the surface, and wherein the porous hydroxyapatite has porosity levels in a range of 30 percent to 80 percent. 6. The intracorporeal marker of claim 5 , wherein the hydroxyapatite body changes in porosity from the first dense hydroxyapatite at the central region to the porous hydroxyapatite at the intermediate region and changes in porosity from the porous hydroxyapatite at the intermediate region to the second dense hydroxyapatite at the surface. 7. An intracorporeal tissue marker, comprising first and second distinct materials, the first material comprising a core of the marker and having a first density, the second material completely surrounding the first material and having a second density, the first density being lower than the second density, and wherein each of the first material and the second material comprises hydroxyapatite. 8. The intracorporeal marker of claim 7 , wherein the first material comprises a porous hydroxyapatite and the second material comprises hydroxyapatite having a density greater than the porous hydroxyapatite. 9. The intracorporeal marker of claim 7 , further comprising a third material completely surrounded by the first material, the first density being lower than the third density. 10. The intracorporeal marker of claim 9 , wherein each of the first material, the second material, and the third material comprises hydroxyapatite. 11. The intracorporeal marker of claim 9 , wherein the first material comprises porous hydroxyapatite having porosity levels in a range of 30 percent to 80 percent, and each of the second material and the third material comprises hydroxyapatite having a porosity lower than the porous hydroxyapatite.

Assignees

Inventors

Classifications

  • involving the use of contrast agents, e.g. microbubbles introduced into the bloodstream · CPC title

  • Radiopaque markers visible in an X-ray image · CPC title

  • Soft tissue, e.g. breast tissue · CPC title

  • ultrasonic · CPC title

  • using X-rays, e.g. fluoroscopy · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9579077B2 cover?
An intracorporeal marker for marking a site within living tissue of a host having a body of porous hydroxyapatite whose physical properties permit the body to be distinguished from human soft tissue under visualization using ultrasonic and radiation imaging modalities.
Who is the assignee on this patent?
Casanova R Michael, Talpade Dnyanesh A, Pathak Chandrashekhar P, and 1 more
What technology area does this patent fall under?
Primary CPC classification A61B90/39. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).